COVID-19
Conditions
Brief summary
The lymphocyte/CRP ratio has been studied many times in covid-19 patients and has been proven to be an indicator of mortality as well as poor prognosis. In this study, the role of the lymphocyte/procalcitonin ratio in predicting the hospitalization status of patients, detection of findings on CT, need for mechanical ventilation, mortality and survival is aimed to be determined. The lymphocyte/procalcitonin ratio was found to be the strongest predictor of mortality and poor prognosis, especially in patients over 65 years of age.
Detailed description
The lymphocyte/CRP ratio has been studied many times in covid-19 patients and has been proven to be an indicator of mortality as well as poor prognosis. In this study, the role of the lymphocyte/procalcitonin ratio in predicting the hospitalization status of patients, detection of findings on CT, need for mechanical ventilation, mortality and survival is aimed to be determined. The lymphocyte/procalcitonin ratio was found to be the strongest predictor of mortality and poor prognosis, especially in patients over 65 years of age. The auc value, PPV and specificity of the lymphocyte/procalcitonin ratio were higher than the lymphocyte/CRP ratio.
Interventions
None listed
Sponsors
Suleyman Demirel University
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
23 Years to 100 Years
Healthy volunteers
No
Inclusion criteria
* Covid19 PCR test positive
Exclusion criteria
* Pregnancy Under 18 years old
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| outcome | 30 days | The relationship between lymphocyte/procalcitonin ratio and 30-day mortality was analyzed. |
Countries
Turkey (Türkiye)
Outcome results
None listed